Medicines Company (MDCO)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 31.15 / 84.98
Exchange NASDAQ
Div & Yield N.A. (N.A)

Latest News

Jim Cramer: Think Stocks Are Too Pricey? These Big Takeovers Prove They're Not

Jim Cramer: Think Stocks Are Too Pricey? These Big Takeovers Prove They're Not

We're seeing lots of companies snapping up their peers, and the market is applauding.

Medicines Co. and Novartis

Positive Developments for These 3 Biotech Stocks

Positive Developments for These 3 Biotech Stocks

We review Acadia Pharmaceuticals, The Medicines Company, and Flexion Therapeutics.

These 5 Small Caps Are Well Positioned Despite Escalating Trade Tensions

These 5 Small Caps Are Well Positioned Despite Escalating Trade Tensions

They're the kind of names, along with a big dollop of cash in my portfolio, I plan to wait out the 'trade wars'.

These 2 Stocks Are on the Move

After an initial burst upward to start trading on Monday, indices have slowly pulled back from their highest levels of the day. Shipping stocks are having a good day on the resumption of trade talks between the U.S. and China. The stock of Hooker Fu...

These 3 Biotech Stocks Are Attracting Insider Buying

These 3 Biotech Stocks Are Attracting Insider Buying

What are insiders buying as the market sells off in recent trading sessions?

Insider Buying Is Still Alive and Well at These 3 Companies

Insider Buying Is Still Alive and Well at These 3 Companies

Insider purchases have tapered off from their frenzied pace in late 2018, but here are three names where such buying is evident.

Biotech and Beyond: 8 Favorite Healthcare Stocks for 2019

Biotech and Beyond: 8 Favorite Healthcare Stocks for 2019

From small-cap genetics and biotech firms to large-cap drug distributors and pharmacies, eight experts select their top picks in the space for this year.

Melinta Up After Deal for Medicines' Infectious Disease Unit -- Biotech Movers

Melinta Up After Deal for Medicines' Infectious Disease Unit -- Biotech Movers

The New Haven, Conn.-based firm on Nov. 29 unveiled a deal to acquire The Medicines Co.'s infectious disease unit.

MacroGenics Soars on Collaboration with Incyte -- Biotech Movers

MacroGenics Soars on Collaboration with Incyte -- Biotech Movers

MacroGenics and Incyte on Wednesday unveiled a collaboration and license agreement regarding MGA012, MacroGenics' investigational monoclonal antibody that inhibits programmed cell death protein 1.

The Medicines Group Rises, More Gains Coming

Market maintaining momentum and Dow right at the 20,000 milestone as we have one hour left in a very encouraging opening week in the market, provided you are not in department store names this week. Neiman Marcus pulls its IPO, with the news from Ma...

Prepare for Biotech Action Aplenty Today

As we await the jobs report, there is significant news across the biotech sector in the past 24 hours on some names I have mentioned in these pages. Amgen should be up nicely today after a judge stated that Regeneron would have to pull its PCKS9 inh...

Market Wrap: Manic Month Ends With a Loss

Market Wrap: Manic Month Ends With a Loss

Energy stocks rally as price of oil climbs.

Medicines Company upgraded at Jefferies

Medicines Company upgraded at Leerink

Medicines Co. downgraded at Leerink

Morning Market Look

Let's take a look at the overnight and early-morning price action in the major asset classes. This is dedicated to our dysfunctional leaders in Washington, D.C. : We met at a party last week And the moment your eyes looked into mine  Right then I ju...

Pulling for a Pullback

Pulling for a Pullback

It's the close that counts.